Genetic and biochemical analysis of ACE inhibitor-induced angioedema in black and coloured South Africans

Angiotensin converting enzyme inhibitors (ACEi) are routinely used as first line treatment for hypertensive patients because of their protective effects against heart and kidney disease. Despite their clinical benefits, ACEi used is associated with adverse side effects such as life threatening angioedema (ACEi-AE) and persistent dry cough (ACEi-cough)

Grantor dc:publisher.institution

Division of Medical Biochemistry

Year dc:date.issued

2011

Author dc:creator

• Moholisa, Retsilisitsoe Raymond

Advisor dc:contributor.advisor

• Sturrock, Edward D

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/11427/11480

OAI identifier oai:identifier

oai:open.uct.ac.za:11427/11480